CUCONATO, GIADA
 Distribuzione geografica
Continente #
EU - Europa 96
NA - Nord America 87
AS - Asia 69
SA - Sud America 14
AF - Africa 7
Totale 273
Nazione #
US - Stati Uniti d'America 82
IT - Italia 55
SG - Singapore 22
CN - Cina 21
RU - Federazione Russa 14
BR - Brasile 10
HK - Hong Kong 9
DE - Germania 8
VN - Vietnam 7
FR - Francia 4
GB - Regno Unito 4
JP - Giappone 4
ZA - Sudafrica 4
BD - Bangladesh 3
CH - Svizzera 3
MA - Marocco 2
MX - Messico 2
PY - Paraguay 2
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
CA - Canada 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
FI - Finlandia 1
IN - India 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SV - El Salvador 1
TR - Turchia 1
Totale 273
Città #
San Jose 18
Singapore 15
Milan 12
Ashburn 10
Rome 10
Beijing 9
Hong Kong 8
Boardman 7
Council Bluffs 6
Los Angeles 5
Moscow 5
Buffalo 3
Chicago 3
Düsseldorf 3
Hamburg 3
Johannesburg 3
Naples 3
Turin 3
Zurich 3
Biên Hòa 2
Cremona 2
Dallas 2
Hanoi 2
Lauterbourg 2
New York 2
Osio Sotto 2
Pavia 2
Santa Clara 2
Shanghai 2
Smethwick 2
Treviso 2
Asunción 1
Attock City 1
Belo Horizonte 1
Besançon 1
Boston 1
Brno 1
Cairo 1
Cape Town 1
Casablanca 1
Castelraimondo 1
Changzhou 1
Chengdu 1
Chennai 1
Cochabamba 1
Dhaka 1
Elk Grove Village 1
Estrela dOeste 1
Evanston 1
Florence 1
Floreşti 1
Greater Sudbury 1
Haikou 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
Istanbul 1
Juárez 1
Kanazawa 1
Kowloon City 1
Krakow 1
Liège 1
Machala 1
Magenta 1
Mexico City 1
Munich 1
Natal 1
Ninh Bình 1
North Kansas City 1
Nossa Senhora do Socorro 1
Olbendorf 1
Orem 1
Orlando 1
Parma 1
Petrolina 1
Piscataway 1
Rio de Janeiro 1
San Salvador 1
Santa Rita 1
Santo Domingo 1
Simolândia 1
Sorocaba 1
South Ockendon 1
São Paulo 1
Tokyo 1
Việt Trì 1
Volta Redonda 1
Totale 209
Nome #
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 106
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 69
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 51
An innovative and effective NGS-based protocol for GBA1 gene analysis in Parkinson disease. 43
RAB32 mutation in Parkinson's disease [2] 5
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 4
LONG-NEXT: A new accurate and efficient NGS-based method for GBA1 analysis in Parkinson disease 2
Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review 2
Male sex accelerates cognitive decline in GBA1 Parkinson’s disease 2
Totale 284
Categoria #
all - tutte 1.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 4 6 4 0 3 12 6
2024/202576 3 3 2 0 1 10 15 5 17 4 4 12
2025/2026173 8 3 14 11 16 4 20 8 15 6 52 16
Totale 284